Pharmafile Logo

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

New team members

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

We’re delighted to announce several new additions to the Cuttsy+Cuttsy team, as we continue to grow and strengthen our capabilities.

Joining us this month are four talented individuals who bring fresh skills, energy, and expertise to help us deliver impactful solutions for our clients, patients, and the wider communities we serve.

Please give a warm welcome to our newest team members:

  • Michelle Packeisen joins as Client Services Team Administrator, providing vital support to ensure our operations run smoothly and efficiently.
  • Jay Laxton steps into the role of Account Executive, bringing enthusiasm and a keen eye for detail to client projects.
  • Emily Purkiss starts her journey as Associate Medical Writer, contributing her expertise to deliver engaging and meaningful content.

We’re also delighted to welcome back Sally Ram, who returns to Cuttsy+Cuttsy after two years to rejoin as an Account Director. Sally brings with her valuable experience from her time away and is ready to make an immediate impact in her new role.

Speaking about her return, Sally shared, “It feels fantastic to be back at Cuttsy+Cuttsy! I’ve missed the incredible team, and I’m excited to get stuck into my new role, building meaningful connections and delivering work that truly makes a difference.”

With these new faces on board (and one familiar one!), we’re more excited than ever for the bright future ahead. Please join us in welcoming Michelle, Jay, Emily, and Sally. We look forward to seeing all the great things they’ll accomplish!

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Caring for patients’ mental health in clinical trials

We look at why ensuring continuous mental health support for patients in clinical trials is essential to enhance their overall well-being and trial engagement.

Driving equitable healthcare: The role of DE&I in clinical trials

Diversity, equity and inclusion (DE&I) is becoming a bigger topic of conversation and meaningful action within clinical trials. And for good reason, too. Find out why we embrace this and...

Empowering patients through more accessible clinical trial information

Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

The digital prescription – enhancing the patient experience with technology

We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...